University of Victoria-Genome British Columbia Proteomics Centre, Vancouver Island Technology Park #3101, 4464 Markham St., Victoria, BC, Canada.
Mol Cell Proteomics. 2013 Mar;12(3):781-91. doi: 10.1074/mcp.M112.022442. Epub 2012 Dec 7.
Dried blood spot (DBS) sampling, coupled with multiple reaction monitoring mass spectrometry (MRM-MS), is a well-established approach for quantifying a wide range of small molecule biomarkers and drugs. This sampling procedure is simpler and less-invasive than those required for traditional plasma or serum samples enabling collection by minimally trained personnel. Many analytes are stable in the DBS format without refrigeration, which reduces the cost and logistical challenges of sample collection in remote locations. These advantages make DBS sample collection desirable for advancing personalized medicine through population-wide biomarker screening. Here we expand this technology by demonstrating the first multiplexed method for the quantitation of endogenous proteins in DBS samples. A panel of 60 abundant proteins in human blood was targeted by monitoring proteotypic tryptic peptides and their stable isotope-labeled analogs by MRM. Linear calibration curves were obtained for 40 of the 65 peptide targets demonstrating multiple proteins can be quantitatively extracted from DBS collection cards. The method was also highly reproducible with a coefficient of variation of <15% for all 40 peptides. Overall, this assay quantified 37 proteins spanning a range of more than four orders of magnitude in concentration within a single 25 min LC/MRM-MS analysis. The protein abundances of the 33 proteins quantified in matching DBS and whole blood samples showed an excellent correlation, with a slope of 0.96 and an R(2) value of 0.97. Furthermore, the measured concentrations for 80% of the proteins were stable for at least 10 days when stored at -20 °C, 4 °C and 37 °C. This work represents an important first step in evaluating the integration of DBS sampling with highly-multiplexed MRM for quantitation of endogenous proteins.
干血斑 (DBS) 采样与多重反应监测质谱 (MRM-MS) 相结合,是一种广泛用于定量分析各种小分子生物标志物和药物的成熟方法。与传统的血浆或血清样本相比,这种采样方法更简单、侵入性更小,允许由训练有素的人员进行采集。许多分析物在 DBS 格式中稳定,无需冷藏,这降低了在偏远地区采集样本的成本和物流挑战。这些优势使 DBS 样本采集成为通过人群生物标志物筛查推进个性化医学的理想选择。在这里,我们通过展示用于 DBS 样本中内源性蛋白质定量的首个多重方法来扩展这项技术。通过监测人血液中 60 种丰富蛋白质的特征性胰蛋白酶肽及其稳定同位素标记的类似物,对其进行了 MRM 定量。对于 65 个肽靶标中的 40 个,获得了线性校准曲线,证明可以从 DBS 采集卡中定量提取多种蛋白质。该方法也具有高度可重复性,所有 40 个肽的变异系数均<15%。总体而言,该测定法在单个 25 分钟 LC/MRM-MS 分析中定量了 37 种蛋白质,涵盖了浓度范围超过四个数量级。在匹配的 DBS 和全血样本中定量的 33 种蛋白质的蛋白丰度具有极好的相关性,斜率为 0.96,R(2)值为 0.97。此外,当在-20°C、4°C 和 37°C 下储存时,80%的蛋白质的测量浓度至少稳定 10 天。这项工作代表了评估 DBS 采样与用于内源性蛋白质定量的高度多重 MRM 集成的重要第一步。